Page last updated: 2024-10-29

itraconazole and Carcinoma, Basal Cell, Pigmented

itraconazole has been researched along with Carcinoma, Basal Cell, Pigmented in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Particularly due to its link to cancer, small molecule Hh pathway inhibitors have been developed and the first compounds have been approved for use in Hh-driven basal cell carcinoma."2.61Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies. ( Dempwolff, L; Diederich, WE; Galperin, I; Lauth, M, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Teske, KA1
Dash, RC1
Morel, SR1
Chau, LQ1
Wechsler-Reya, RJ1
Hadden, MK1
Galperin, I1
Dempwolff, L1
Diederich, WE1
Lauth, M1

Reviews

1 review available for itraconazole and Carcinoma, Basal Cell, Pigmented

ArticleYear
Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies.
    Journal of medicinal chemistry, 2019, 09-26, Volume: 62, Issue:18

    Topics: Animals; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Approval; Drug Design; Hedgehog Proteins

2019

Other Studies

1 other study available for itraconazole and Carcinoma, Basal Cell, Pigmented

ArticleYear
Development of posaconazole-based analogues as hedgehog signaling pathway inhibitors.
    European journal of medicinal chemistry, 2019, Feb-01, Volume: 163

    Topics: Antifungal Agents; Carcinoma, Basal Cell; Hedgehog Proteins; Humans; Molecular Dynamics Simulation;

2019